CLINUVEL PHARMACEUTICALS LTD is pleased to announce that it will issue a dividend for the financial year ended 30 June 2019. This is the second final dividend in its corporate history.
Recent Posts
SCENESSE® registration dossier submitted in Australia
CLINUVEL initiates the registration process under priority review for its new pharmaceutical...
Read More
Notice of Change of Interests of Substantial Holder
Form 604 – Notice of change of interests of substantial holder...
Read More